Mainz Biomed NV
NASDAQ:QUCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mainz Biomed NV
NASDAQ:QUCY
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is QUCY's stock price target?
Not Available
QUCY doesn't have any price targets made by Wall Street professionals.
What is Mainz Biomed NV's Revenue forecast?
Projected CAGR
142%
For the last 4 years the
compound annual growth rate for
Mainz Biomed NV's revenue is
16%.
The projected
CAGR
for the next 4 years is
142%.